Liberty Global PLC Class B (LBTYB) had the highest return between January 3, 2025 and January 8, 2025 by a mid-cap US stock, returning 69.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Liberty Global PLC Class B (LBTYB) | 1/3/2025 - 1/8/2025 | 69.9% |
Inari Medical (NARI) | 1/3/2025 - 1/8/2025 | 51.54% |
Canoo (GOEVW) | 1/3/2025 - 1/8/2025 | 26.96% |
Unifirst (UNF) | 1/3/2025 - 1/8/2025 | 25.95% |
GDS (GDS) | 1/3/2025 - 1/8/2025 | 22.36% |
GeneDx (WGS) | 1/3/2025 - 1/8/2025 | 21.98% |
Paycor HCM (PYCR) | 1/3/2025 - 1/8/2025 | 20.69% |
Oklo (OKLO) | 1/3/2025 - 1/8/2025 | 18.94% |
MP Materials (MP) | 1/3/2025 - 1/8/2025 | 17.1% |
Advantage Solutions (ADVWW) | 1/3/2025 - 1/8/2025 | 16.54% |
Joby Aviation (JOBY) | 1/3/2025 - 1/8/2025 | 15.66% |
Plug Power (PLUG) | 1/3/2025 - 1/8/2025 | 14.59% |
Guardant Health (GH) | 1/3/2025 - 1/8/2025 | 14.13% |
Riot Blockchain (RIOT) | 1/3/2025 - 1/8/2025 | 13.77% |
Inspire Medical Systems (INSP) | 1/3/2025 - 1/8/2025 | 12.34% |
NeoGenomics (NEO) | 1/3/2025 - 1/8/2025 | 12.24% |
SpringWorks Therapeutics (SWTX) | 1/3/2025 - 1/8/2025 | 12.13% |
Calix (CALX) | 1/3/2025 - 1/8/2025 | 12.03% |
Agios Pharm (AGIO) | 1/3/2025 - 1/8/2025 | 11.98% |
Camtek (CAMT) | 1/3/2025 - 1/8/2025 | 11.97% |
Oscar Health (OSCR) | 1/3/2025 - 1/8/2025 | 11.77% |
Halozyme Therapeutics (HALO) | 1/3/2025 - 1/8/2025 | 11.54% |
Onto Innovation (ONTO) | 1/3/2025 - 1/8/2025 | 11.48% |
Arcadium Lithium (ALTM) | 1/3/2025 - 1/8/2025 | 9.83% |
Acadia Healthcare (ACHC) | 1/3/2025 - 1/8/2025 | 9.65% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
